Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valeant Internat Barbados SrlfiledCriticalValeant Internat Barbados Srl
Priority to MYPI20060143ApriorityCriticalpatent/MY145995A/en
Publication of MY145995ApublicationCriticalpatent/MY145995A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicinal Preparation
(AREA)
Abstract
A MODIFIED-RELEASE TABLET OF BUPROPION HYDROCHLORIDE COMPRISING (I) A CORE COMPRISING AN EFFECTIVE AMOUNT OF BUPROPION HYDROCHLORIDE, A BINDER, A LUBRICANT; AND (II) A CONTROL RELEASING COAT SURROUNDING SAID CORE; AND (III) A MOISTURE BARRIER SURROUNDING SAID CONTROL RELEASING COAT, WHEREIN THE MODIFIED-RELEASE TABLET IS BIOEQUIVALENT TO WELLBUTRIN® OR ZYBAN®/WELLBUTRIN®SR TABLETS.
MYPI20060143A2006-01-122006-01-12Modified-release tablet of bupropion hydrochloride
MY145995A
(en)
Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values